These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 11043675

  • 1. Chiral high-performance liquid chromatographic analysis of fluoxetine and norfluoxetine in rabbit plasma, urine, and vitreous humor using an acetylated beta-cyclodextrin column.
    Yee L, Wong SH, Skrinska VA.
    J Anal Toxicol; 2000 Oct; 24(7):651-5. PubMed ID: 11043675
    [Abstract] [Full Text] [Related]

  • 2. Trace analysis of fluoxetine and its metabolite norfluoxetine. Part I: development of a chiral liquid chromatography-tandem mass spectrometry method for wastewater samples.
    Barclay VK, Tyrefors NL, Johansson IM, Pettersson CE.
    J Chromatogr A; 2011 Aug 19; 1218(33):5587-96. PubMed ID: 21752386
    [Abstract] [Full Text] [Related]

  • 3. Ultrasound-assisted dispersive liquid-liquid microextraction coupled with field-amplified capillary electrophoresis for sensitive and quantitative determination of fluoxetine and norfluoxetine enantiomers in biological fluids.
    Wang ZR, Hsieh MM.
    Anal Bioanal Chem; 2020 Aug 19; 412(21):5113-5123. PubMed ID: 32162085
    [Abstract] [Full Text] [Related]

  • 4. A validated enantioselective assay for the simultaneous quantitation of (R)-, (S)-fluoxetine and (R)-, (S)-norfluoxetine in ovine plasma using liquid chromatography with tandem mass spectrometry (LC/MS/MS).
    Chow TW, Szeitz A, Rurak DW, Riggs KW.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb 15; 879(5-6):349-58. PubMed ID: 21242112
    [Abstract] [Full Text] [Related]

  • 5. Determination of fluoxetine and norfluoxetine by high-performance liquid chromatography.
    Wong SH, Dellafera SS, Fernandes R, Kranzler H.
    J Chromatogr; 1990 Jan 19; 499():601-8. PubMed ID: 2324217
    [Abstract] [Full Text] [Related]

  • 6. High-performance liquid chromatographic determination of (S)- and (R)-propranolol in human plasma and urine with a chiral beta-cyclodextrin bonded phase.
    Pham-Huy C, Radenen B, Sahui-Gnassi A, Claude JR.
    J Chromatogr B Biomed Appl; 1995 Mar 10; 665(1):125-32. PubMed ID: 7795782
    [Abstract] [Full Text] [Related]

  • 7. Enantioselective quantification of fluoxetine and norfluoxetine by HPLC in wastewater effluents.
    Ribeiro AR, Maia AS, Moreira IS, Afonso CM, Castro PM, Tiritan ME.
    Chemosphere; 2014 Jan 10; 95():589-96. PubMed ID: 24184049
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization.
    Suckow RF, Zhang MF, Cooper TB.
    Clin Chem; 1992 Sep 10; 38(9):1756-61. PubMed ID: 1526010
    [Abstract] [Full Text] [Related]

  • 10. Cyclodextrins as a chiral mobile phase additive in nano-liquid chromatography: comparison of reversed-phase silica monolithic and particulate capillary columns.
    Rocco A, Maruška A, Fanali S.
    Anal Bioanal Chem; 2012 Mar 10; 402(9):2935-43. PubMed ID: 22349325
    [Abstract] [Full Text] [Related]

  • 11. Solid-phase microextraction-liquid chromatography (SPME-LC) determination of fluoxetine and norfluoxetine in plasma using a heated liquid flow through interface.
    Fernandes C, Neto AJ, Rodrigues JC, Alves C, Lanças FM.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar 01; 847(2):217-23. PubMed ID: 17081810
    [Abstract] [Full Text] [Related]

  • 12. Issues in methodology and applications for therapeutic drug monitoring of fluoxetine and norfluoxetine enantiomers.
    Zuccaro P, Pacifici R, Altieri I, Avenoso A, Pellegrini M, Spina E, Perucca E, Pichini S.
    Ther Drug Monit; 1998 Feb 01; 20(1):20-4. PubMed ID: 9485549
    [Abstract] [Full Text] [Related]

  • 13. Three-phase, liquid-phase microextraction combined with high performance liquid chromatography-fluorescence detection for the simultaneous determination of fluoxetine and norfluoxetine in human plasma.
    de Freitas DF, Porto CE, Vieira EP, de Siqueira ME.
    J Pharm Biomed Anal; 2010 Jan 05; 51(1):170-7. PubMed ID: 19683889
    [Abstract] [Full Text] [Related]

  • 14. [Enantioseparation and determination of atenolol enantiomers in tables on a β-cyclodextrin-based chiral stationary phase by high performance liquid chromatography].
    Cheng B, Li L, Zhou R, Nie G, Zhang H.
    Se Pu; 2014 Nov 05; 32(11):1219-24. PubMed ID: 25771541
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous determination of fluoxetine and norfluoxetine enantiomers in biological samples by gas chromatography with electron-capture detection.
    Torok-Both GA, Baker GB, Coutts RT, McKenna KF, Aspeslet LJ.
    J Chromatogr; 1992 Aug 07; 579(1):99-106. PubMed ID: 1447355
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Quantification of fluoxetine and norfluoxetine serum levels by reversed-phase high-performance liquid chromatography with ultraviolet detection.
    Holladay JW, Dewey MJ, Yoo SD.
    J Chromatogr B Biomed Sci Appl; 1997 Dec 19; 704(1-2):259-63. PubMed ID: 9518159
    [Abstract] [Full Text] [Related]

  • 19. Sensitive liquid chromatographic-tandem mass spectrometric method for the determination of fluoxetine and its primary active metabolite norfluoxetine in human plasma.
    Sutherland FC, Badenhorst D, de Jager AD, Scanes T, Hundt HK, Swart KJ, Hundt AF.
    J Chromatogr A; 2001 Apr 20; 914(1-2):45-51. PubMed ID: 11358229
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.